Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore

被引：0
|
作者：
Scott D. Lee
Jessica R. Allegretti
Flavio Steinwurz
Susan B. Connelly
Nervin Lawendy
Jerome Paulissen
Krisztina B. Gecse
机构：
[1] University of Washington Medical Center,Digestive Health Center
[2] Brigham and Women’s Hospital,Division of Gastroenterology, Hepatology and Endoscopy
[3] Hospital Israelita Albert Einstein,Unit of Inflammatory Bowel Disease
[4] Pfizer Inc,undefined
[5] Pfizer Inc,undefined
[6] Amsterdam UMC,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Efficacy; Tofacitinib; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme
    Schreiber, Stefan
    Rubin, David T.
    Ng, Siew C.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Modesto, Irene
    Guo, Xiang
    Su, Chinyu
    Kwok, Kenneth K.
    Jo, Hyejin
    Chen, Yan
    Yndestad, Arne
    Reinisch, Walter
    Dubinsky, Marla C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (11): : 1761 - 1770
  • [42] Ulcerative Colitis: Tofacitinib as Long-Term Maintenance Therapy after Remission
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (03): : 284 - 285
  • [43] One year endoscopic and histologic outcomes to tofacitinib therapy in refractory ulcerative colitis
    Verstockt, B.
    Aden, K.
    Alsoud, D.
    Outtier, A.
    Sabino, J.
    Rosenstiel, P.
    Vermeire, S.
    De Hertogh, G.
    Schreiber, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S456 - S457
  • [44] ONE YEAR ENDOSCOPIC AND HISTOLOGIC OUTCOMES TO TOFACITINIB THERAPY IN REFRACTORY ULCERATIVE COLITIS
    Verstockt, Bram
    Alsoud, Dahham
    Outtier, An
    Sabino, Joao
    Vermeire, Severine
    De Hertogh, Gert
    Ferrante, Marc
    GASTROENTEROLOGY, 2021, 160 (06) : S702 - S702
  • [45] Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study
    Vavricka, Stephan R.
    Greuter, Thomas
    Cohen, Benjamin L.
    Reinisch, Walter
    Steinwurz, Flavio
    Fellmann, Marc
    Guo, Xiang
    Lawendy, Nervin
    Paulissen, Jerome
    Peyrin-Biroulet, Laurent
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [46] Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study
    Vavricka, S. R.
    Greuter, T.
    Cohen, B. L.
    Reinisch, W.
    Steinwurz, F.
    Fellmann, M.
    Guo, X.
    Lawendy, N.
    Paulissen, J.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S116 - S117
  • [47] Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center
    Suttichaimongkol, Tanita
    Coelho-Prabhu, Nayantara
    Bruining, David H.
    Tariq, Raseen
    Snyder, Melissa R.
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [48] EFFICACY AND SAFETY OF DOSE ESCALATION TO TOFACITINIB 10 MG BID FOR PATIENTS WITH ULCERATIVE COLITIS FOLLOWING LOSS OF RESPONSE ON TOFACITINIB 5 MG BID MAINTENANCE THERAPY: RESULTS FROM OCTAVE OPEN
    Sands, Bruce E.
    Moss, Alan C.
    Armuzzi, Alessandro
    Marshall, John K.
    Lindsay, James O.
    Sandborn, William J.
    Danese, Silvio
    Tsilkos, Konstantinos
    Lawendy, Nervin
    Zhang, Haiying
    Friedman, Gary S.
    Chan, Gary
    Krichbaum, Daniel W.
    Su, Chinyu
    GASTROENTEROLOGY, 2018, 154 (06) : S385 - S385
  • [49] TOFACITINIB SALVAGE THERAPY IN PEDIATRIC PATIENTS HOSPITALIZED FOR ULCERATIVE COLITIS
    Kirsch, Jacqueline
    Stein, Ronen E.
    Baldassano, Robert N.
    Albenberg, Lindsey
    Constant, Brad D.
    GASTROENTEROLOGY, 2022, 162 (07) : S642 - S643
  • [50] Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
    Rubin, David T.
    Reinisch, Walter
    Greuter, Thomas
    Kotze, Paulo G.
    Pinheiro, Marcia
    Mundayat, Rajiv
    Maller, Eric
    Fellmann, Marc
    Lawendy, Nervin
    Modesto, Irene
    Vavricka, Stephan R.
    Lichtenstein, Gary R.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
12345